Effect of Science Research Wellness Ndo1 on Glycaemia in Adults With Pre-diabetes (NCT06897462) | Clinical Trial Compass
CompletedNot Applicable
Effect of Science Research Wellness Ndo1 on Glycaemia in Adults With Pre-diabetes
China14 participantsStarted 2025-04-01
Plain-language summary
The objective of this study is to test the effect of 12 weeks of supplementation SRW Ndo1 on metabolic health and general health in adults with prediabetes. The primary question it aims to answer are:
* How does SRW Ndo1 affect the Haemoglobin A1C (HbA1C) test outcome for adult individuals?
* How does SRW Ndo1 affect the body measures and blood pressures of adult individuals?
Investigators will compare the supplement to a placebo (a look-alike substance that contains no supplement) to see if SRW Ndo1 works to support normal blood sugar metabolism.
Participants will:
* Take supplement SRW Ndo1, two capsules a day for 12 weeks.
* Be asked to refrain from changing their diet and lifestyle drastically during the study and to refrain from starting new health supplements during the study.
* Visit the clinic at the start and the end of intervention for a blood test (8 hour fasting required prior to test)
* Keep a diary of their symptoms or adverse events during intervention.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age 18 years and over.
✓. Prediabetes, defined as fasting plasma glucose of 6.1-6.9 mmol/L and/or HbA1c of 5.7-6.4% and/or 2 h plasma glucose of 7.8-11.0 mmol/L after ingestion of 75 g of oral glucose load. Blood tests conducted within 3 months before randomisation will be accepted.
✓. Able to read and write English.
✓. Has access to internet.
✓. Provided informed consent to participate in the study.
Exclusion criteria
✕. Has a medical condition known to affect the glycaemia.
✕. Regular intake of a health supplement with effects on glycaemia.
✕. Currently participating in another trial/study of a supplement or drug.
✕. Has any known food or allergy or intolerances to the ingredients of the intervention.
✕. Pregnant, trying to conceive or breastfeeding.
What they're measuring
1
Serum Hemoglobin A1C (HbA1c) concentration
Timeframe: From enrollment to the end of treatment at 12 weeks